News
Late-stage results Otsuka presented in IgA nephropathy triggered a sell-off in Vera shares. Elsewhere, investors scrutinized ...
Investor's Business Daily on MSN18h
The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback